Translating basic research in cancer patient care

Ruggero De Maria Marchiano, Marcello Maugeri-Saccà

Research output: Contribution to journalArticle

3 Citations (Scopus)


With the advent of molecular targeted therapies and the development of high-throughput biotechnologies, it has become evident that progress in cancer research is largely due to the creation of multidisciplinary teams able to plan clinical trials supported by appropriate molecular hypoth- eses. These efforts have culminated in the identi cation and validation of biomarkers predictive of response, as well as in the generation of more accurate prognostic tools. The identi cation of cancer stem cells has provided further insights into mechanisms of cancer, and many studies have tried to translate this biological notion into prognostic and predictive information. In this regard, new agents targeting key stemness-related pathways have entered the clinical development, and prelimi- nary data suggested an encouraging antitumor activity.
Original languageEnglish
Pages (from-to)64-71
Number of pages8
Publication statusPublished - 2011


  • Biomarkers, Tumor
  • Clinical Trials as Topic
  • Humans
  • Medical Oncology
  • Molecular Targeted Therapy
  • Neoplasms
  • Neoplastic Stem Cells
  • Precision Medicine
  • Predictive Value of Tests
  • Reproducibility of Results
  • Translational Medical Research


Dive into the research topics of 'Translating basic research in cancer patient care'. Together they form a unique fingerprint.

Cite this